According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical care facility stocks to buy right now are:
1. Aveanna Healthcare Holdings (NASDAQ:AVAH)
The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: C, and AI: B.
Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 30, which is 1 points higher than the medical care facility industry average of 29.
AVAH passed 10 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 47.27% over the past year, overperforming other medical care facility stocks by 78 percentage points.
Aveanna Healthcare Holdings has an average 1 year
price target of $7.92, a downside of -2.26% from Aveanna Healthcare Holdings's current stock price of $8.10.
Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Enhabit (NYSE:EHAB)
Enhabit (NYSE:EHAB) is the #2 top medical care facility stock out of 47 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Enhabit (NYSE:EHAB) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: A, Financials: C, and AI: C.
Enhabit (NYSE:EHAB) has a Due Diligence Score of 7, which is -22 points lower than the medical care facility industry average of 29. Although this number is below the industry average, our proven quant model rates EHAB as a "A".
EHAB passed 2 out of 33 due diligence checks and has weak fundamentals. Enhabit has seen its stock lose -0.73% over the past year, overperforming other medical care facility stocks by 30 percentage points.
Enhabit has an average 1 year
price target of $8.50, an upside of 3.91% from Enhabit's current stock price of $8.18.
Enhabit stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Enhabit, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Ardent Health Partners (NYSE:ARDT)
The Component Grade breakdown for Ardent Health Partners (NYSE:ARDT) is: Value: A, Growth: B, Momentum: D, Sentiment: B, Safety: A, Financials: B, and AI: C.
Ardent Health Partners (NYSE:ARDT) has a Due Diligence Score of 48, which is 19 points higher than the medical care facility industry average of 29.
ARDT passed 16 out of 33 due diligence checks and has strong fundamentals. Ardent Health Partners has seen its stock lose -28.66% over the past year, overperforming other medical care facility stocks by 2 percentage points.
Ardent Health Partners has an average 1 year
price target of $18.08, an upside of 40.99% from Ardent Health Partners's current stock price of $12.82.
Ardent Health Partners stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Ardent Health Partners, 50% have issued a Strong Buy rating, 25% have issued a Buy, 12.5% have issued a hold, while 12.5% have issued a Sell rating, and 0% have issued a Strong Sell.